Photodynamic fungicidal efficacy of hypericin and dimethyl methylene blue against azole-resistant Candida albicans strains

Mycoses

Volumn 57, Issue 1, 2014, Pages 35-42

  Paz Cristobal, M P ^a   Royo, D ^a   Rezusta, A ^a   Andres Ciriano E ^a   Alejandre, M C ^b   Meis, J F ^c   Revillo, M J ^a   Aspiroz, C ^d,e   Nonell, S ^f   Gilaberte, Y ^e,g  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b Laboratory of Mycrobiology of Water   (Spain)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d HOSPITAL ROYO VILLANOVA   (Spain)

^e INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^f Institut Químic de Sarrià Universitat Ramon Llull   (Spain)

^g HOSPITAL SAN JORGE   (Spain)

Author keywords

1,9 dimethyl methylene blue; Azole resistance; Candida albicans; Hypericin; Photodynamic therapy

Indexed keywords

DIMETHYL METHYLENE BLUE; HYPERICIN; METHYLENE BLUE; PYRROLE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ARTICLE; CANDIDA ALBICANS; CYTOTOXICITY; DRUG EFFICACY; FUNGAL STRAIN; FUNGUS CULTURE; IN VITRO STUDY; LIGHT EMITTING DIODE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

CANDIDA; CANDIDA ALBICANS;

1,9-DIMETHYL METHYLENE BLUE; AZOLE RESISTANCE; CANDIDA ALBICANS; HYPERICIN; PHOTODYNAMIC THERAPY;

ANTIFUNGAL AGENTS; AZOLES; CANDIDA ALBICANS; CANDIDIASIS; COMBINED MODALITY THERAPY; DRUG RESISTANCE, FUNGAL; HUMANS; LIGHT; METHYLENE BLUE; MICROBIAL SENSITIVITY TESTS; PERYLENE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 84890807722     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12099     Document Type: Article

References (34)

1. Howell SA, Hazen KC. Candida, Cryptococcus, and other yeasts of medical importance. In: Murray PR, Baron EJ, Jorgensen J, Pfaller MA, Landry ML (eds), Manual of Clinical Microbiology. Washington DC: American Society for Microbiology, 2011: 1762-88.
2. Hay RJ. The management of superficial candidiasis. J Am Acad Dermatol 1999; 40: S35-42.
3. Taschdjian CL, Kozinn PJ, Toni EF. Opportunistic yeast infections, with special reference to candidiasis. Ann N Y Acad Sci 1970; 174: 606-22.
4. Scully C, el-Kabir M. Candida and oral candidosis: a review. Crit Rev Oral Biol Med 1994; 5: 125-57.
5. Pappas PG, Kauffman CA, Andes D et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 503-35.
6. Kharkwal GB, Sharma SK, Huang YY, Dai T, Hamblin MR. Photodynamic therapy for infections: clinical applications. Lasers Surg Med 2011; 43: 755-67.
7. Bertoloni G, Sacchetto R, Jori G, Vernon DJ, Brown SB. Protoporphyrin photosensitization of Enterococcus hirae and Candida albicans cells. Las Life Sci 1993; 5: 5267-75.
8. Costa AC, Rasteiro VM, Pereira CA, Rossoni RD, Junqueira JC, Jorge AO. The effects of rose bengal- and erythrosine-mediated photodynamic therapy on Candida albicans. Mycoses 2012; 55: 56-63.
9. Rezusta A, López-Chicón P, Paz-Cristobal MP et al. In vitro fungicidal photodynamic effect of hypericin on Candida species. Photochem Photobiol 2012; 88: 613-9.
10. Zeina B, Greenman J, Purcell WM, Das B. Killing of cutaneous microbial species by photodynamic therapy. Br J Dermatol 2001; 144: 274-8.
11. Dai T, Bil de Arce VJ, Tegos GP, Hamblin MR. Blue dye and red light, a dynamic combination for prophylaxis and treatment of cutaneous Candida albicans infections in mice. Antimicrob Agents Chemother 2011; 55: 5710-7.
12. Mima EG, Pavarina AC, Dovigo LN et al. Susceptibility of Candida albicans to photodynamic therapy in a murine model of oral candidosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011; 109: 392-401.
13. Mitra S, Haidaris CG, Snell SB, Giesselman BR, Hupcher SM, Foster TH. Effective photosensitization and selectivity in vivo of Candida albicans by meso-tetra (N-methyl-4-pyridyl) porphine tetra tosylate. Lasers Surg Med 2011; 43: 324-32.
14. Dovigo LN, Pavarina AC, Mima EG, Giampaolo ET, Vergani CE, Bagnato VS. Fungicidal effect of photodynamic therapy against fluconazole-resistant Candida albicans and Candida glabrata. Mycoses 2011; 54: 123-30.
15. Mang TS, Mikulski L, Hall RE. Photodynamic inactivation of normal and antifungal resistant Candida species. Photodiagnosis Photodyn Ther 2010; 2010: 98-105.
16. Wainwright M, Phoenix DA, Gaskell M, Marshall B. Photobactericidal activity of methylene blue derivatives against vancomycin-resistant Enterococcus spp. J Antimicrob Chemother 1999; 1999: 823-5.
17. Ernst EJ, Yodoi K, Roling EE, Klepser ME. Rates and extents of antifungal activities of amphotericin B, flucytosine, fluconazole, and voriconazole against Candida lusitaniae determined by microdilution, Etest, and time-kill methods. Antimicrob Agents Chemother 2002; 46: 578-81.
18. Liao JC, Roider J, Jay DG. Chromophore-assisted laser inactivation of proteins is mediated by the photogeneration of free radicals. Proc Natl Acad Sci USA 1994; 91: 2659-63.
19. Tavares A, Dias SR, Carvalho CM et al. Mechanisms of photodynamic inactivation of a gram-negative recombinant bioluminescent bacterium by cationic porphyrins. Photochem Photobiol Sci 2011; 10: 1659-69.
20. Phoenix DA, Sayed Z, Hussain S, Harris F, Wainwright M. The phototoxicity of phenothiazinium derivatives against Escherichia coli and Staphylococcus aureus. FEMS Immunol Med Microbiol 2003; 39: 17-22.
21. Ragàs X, Dai T, Tegos GP, Agut M, Nonell S, Hamblin MR. Photodynamic inactivation of Acinetobacter baumannii using phenothiazinium dyes: in vitro and in vivo studies. Lasers Surg Med 2010; 42: 384-90.
22. Demidova TN, Hamblin MR. Photodynamic inactivation of Bacillus spores, mediated by phenothiazinium dyes. Appl Environ Microbiol 2005; 71: 6918-25.
23. Pupo YM, Gomes GM, Santos EB et al. Susceptibility of Candida albicans to photodynamic therapy using methylene blue and toluidine blue as photosensitizing dyes. Acta Odontol Latinoam 2011; 2011: 188-92.
24. Teichert MC, Jones JW, Usacheva MN, Biel MA. Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 93: 155-60.
25. Jackson Z, Meghji S, MacRobert A, Henderson B, Wilson M. Killing of the yeast and hyphal forms of Candida albicans using a light-activated antimicrobial agent. Lasers Med Sci 1999; 1999: 150-7.
26. Wainwright M, Phoenix DA, Laycock SL, Wareing DR, Wright PA. Photobactericidal activity of phenothiazinium dyes against methicillin-resistant strains of Staphylococcus aureus. FEMS Microbiol Lett 1998; 160: 177-81.
27. Tanaka M, Kinoshita M, Yoshihara Y et al. Optimal photosensitizers for photodynamic therapy of infections should kill bacteria but spare neutrophils. Photochem Photobiol 2012; 88: 227-32.
28. Wainwright M, Phoenix DA, Rice L, Burrow SM, Waring J. Increased cytotoxicity and phototoxicity in the methylene blue series via chromophore methylation. J Photochem Photobiol, B 1997; 40: 233-9.
29. Giroldo LM, Felipe MP, de Oliveira MA, Munin E, Alves LP, Costa MS. Photodynamic antimicrobial chemotherapy (PACT) with methylene blue increases membrane permeability in Candida albicans. Lasers Med Sci 2009; 24: 109-12.
30. de Souza SC, Junqueira JC, Balducci I, Koga-Ito CY, Munin E, Jorge AO. Photosensitization of different Candida species by low power laser light. J Photochem Photobiol, B 2006; 83: 34-38.
31. Lopez-Chicon P, Paz-Cristobal MP, Rezusta A et al. On the mechanism of Candida spp. photoinactivation by hypericin. Photochem Photobiol Sci 2012; 11: 1099-107.
32. Theodossiou TA, Hothersall JS, De Wittle PA, Pantos A, Agostinis P. The multifaceted photocytotoxic profile of hypericin. Mol Pharm 2009; 6: 1789.
33. Cáp M, Váchová L, Palková Z. Reactive oxygen species in the signalling and adaptation of multicellular microbial communities. Oxid Med Cell Longev 2012; 2012: 976735.
34. Price M, Terkecky SR, Kessel D. A role for hydrogen peroxide in the pro-apoptotic effects of photodynamic therapy. Photochem Photobiol 2009; 85: 1491-6.